State Street Corp Sells 33,324 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

State Street Corp decreased its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 3.6% in the third quarter, HoldingsChannel reports. The institutional investor owned 904,901 shares of the company’s stock after selling 33,324 shares during the period. State Street Corp’s holdings in Phibro Animal Health were worth $20,378,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Brandes Investment Partners LP raised its stake in shares of Phibro Animal Health by 1.2% during the second quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company’s stock valued at $40,521,000 after acquiring an additional 29,071 shares in the last quarter. Dimensional Fund Advisors LP raised its position in Phibro Animal Health by 5.7% during the 2nd quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock valued at $13,005,000 after purchasing an additional 42,086 shares in the last quarter. Acadian Asset Management LLC lifted its holdings in shares of Phibro Animal Health by 6.3% in the 2nd quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock worth $12,027,000 after buying an additional 42,299 shares during the period. Dana Investment Advisors Inc. increased its stake in shares of Phibro Animal Health by 17.2% during the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock valued at $8,619,000 after buying an additional 75,546 shares during the period. Finally, American Century Companies Inc. increased its stake in shares of Phibro Animal Health by 119.6% during the second quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock valued at $5,822,000 after buying an additional 189,068 shares during the period. 99.34% of the stock is owned by hedge funds and other institutional investors.

Phibro Animal Health Price Performance

Shares of PAHC opened at $21.64 on Tuesday. The company has a 50 day moving average of $23.52 and a two-hundred day moving average of $20.77. The company has a market cap of $876.48 million, a price-to-earnings ratio of 50.33, a price-to-earnings-growth ratio of 0.58 and a beta of 0.51. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. Phibro Animal Health Co. has a twelve month low of $10.03 and a twelve month high of $25.98.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were paid a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 annualized dividend and a yield of 2.22%. Phibro Animal Health’s dividend payout ratio (DPR) is 111.63%.

Analysts Set New Price Targets

PAHC has been the topic of several recent research reports. Bank of America increased their target price on shares of Phibro Animal Health from $13.00 to $15.00 and gave the stock an “underperform” rating in a report on Friday, August 30th. Morgan Stanley lifted their price objective on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a report on Tuesday, December 17th. StockNews.com upgraded Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a report on Wednesday, December 18th. Barclays lifted their price target on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a report on Tuesday, November 12th. Finally, JPMorgan Chase & Co. started coverage on Phibro Animal Health in a research note on Tuesday, September 10th. They set a “neutral” rating and a $22.00 price objective for the company. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $20.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.